Archive: 30/12/2019
MIV-711 not associated with pain reduction, but may reduce disease progression in osteoarthritis
MIV-711, a novel selective cathepsin K inhibitor, was not more effective than placebo for reducing pain related to knee osteoarthritis. However, MIV-711 significantly reduced bone and cartilage progression. Findings from ...
Dec 30, 2019